1. Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial)
- Author
-
Victor Arévalos, Francesco Spione, Rami Gabani, Luis Ortega-Paz, Josep Gómez-Lara, Víctor Jiménez-Díaz, Marcelo Jiménez, Pilar Jiménez-Quevedo, Roberto Diletti, Javier Pineda, Gianluca Campo, Antonio Silvestro, Jaume Maristany, Xacobe Flores, Loreto Oyarzabal, Guillermo Bastos-Fernandez, Andrés Iñiguez, Antonio Serra, Javier Escaned, Alfonso Ielasi, Maurizio Tespili, Mattie Lenzen, Antonio Fernández-Ortiz, Pascual Bordes, Matteo Tebaldi, Simone Biscaglia, Soheil Al-Shaibani, Rafael Romaguera, Joan Antoni Gómez-Hospital, Josep Rodes-Cabau, Patrick W. Serruys, Manel Sabaté, Salvatore Brugaletta, and Cardiology
- Subjects
Cardiology and Cardiovascular Medicine - Abstract
The aim of this substudy of the EXAMINATION-EXTEND was to analyze 10-year outcomes according to the patient's age at the time of the first ST-elevation myocardial infarction (STEMI). Of 1,498 patients with STEMI included in the EXAMINATION-EXTEND study, those with a previous history of coronary ischemic even or ischemic stroke were excluded from this analysis. The remaining 1,375 patients were divided into 4 age groups: 75 years. The primary end point was 10-year patient-oriented composite end point (POCE) of all-cause death, any MI, or any revascularization. At 10-year follow-up, patients aged 75 years, led by a lower incidence of all-cause death (75 years: 61.6%, p = 0.001). Cardiac death was more prevalent in the older group (75 years: 35.5%, p = 0.001). In the landmark analyses, between 5- and 10-year follow-up, young patients exhibited a higher incidence of any revascularization (65 years: 1.6%, p = 0.001). In conclusion, in patients with a first STEMI, advanced age was associated with high rates of POCE at 10-year follow-up due to all-cause and cardiac death. Conversely, younger patients exhibited a high risk of revascularization at long-term follow-up.
- Published
- 2023